Mohammed Osman, MD
Interventional Cardiology · Rochester, MNNPI 1124403456
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,804 of the $4,099 with a category attached, or 68.4%. 12 manufacturers reported payments, led by Medtronic at 44.9% of the total. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.
Across 33 payments — averaging $124.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Abbott$940
- Stryker$787
- Cardiovascular Systems Inc.$226
- Inari Medical, Inc.$113
- Cardiva Medical, Inc.$65
- plus $128 from 6 others
What the payments were for
- Travel & lodging$2,80468%
- Food & beverage$1,01525%
- Education$2807%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 14 | $1,840 |
| Abbott | 6 | $940 |
| Stryker | 1 | $787 |
| Cardiovascular Systems Inc. | 3 | $226 |
| Inari Medical, Inc. | 1 | $113 |
| Cardiva Medical, Inc. | 1 | $65 |
| Boston Scientific | 2 | $34 |
| Edwards Lifesciences | 1 | $25 |
| Shockwave Medical, Inc | 1 | $25 |
| Merck | 1 | $16 |
| GSK | 1 | $15 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,099 in reported general payments places this provider in the 40th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $14,147 |
| JardianceEmpagliflozin | 12 | $10,903 |
| Repatha SureclickEvolocumab | 13 | $10,609 |
| EntrestoSacubitril/Valsartan | 11 | $8,449 |
| Rosuvastatin Calcium | 52 | $613 |
| Metoprolol Succinate | 57 | $562 |
| Atorvastatin Calcium | 23 | $379 |
| Nitroglycerin | 15 | $321 |
| ClopidogrelClopidogrel Bisulfate | 27 | $213 |
| Cilostazol | 19 | $195 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 17 | $164 |
| Amlodipine Besylate | 31 | $94 |
| Spironolactone | 18 | $73 |
| Metoprolol Tartrate | 27 | $72 |
| Losartan Potassium | 11 | $61 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Rochester
- Kelley ChenRochester$14K
- Colleen LaneRochester$14K
- Smitha Narayana GowdaRochester$9K
- Trevor SimardRochester$9K
- Michael SabbahRochester$8K
- Aravdeep JhandRochester$7K
- Joshua RezkallaRochester$5K
- Mohammad SarrafRochester$3K
- Jason SimsRochester$2K
- Conor LaneRochester$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.